GoodRx (NASDAQ:GDRX) PT Lowered to $19.00

GoodRx (NASDAQ:GDRX – Get Rating) had its target price lowered by research analysts at Morgan Stanley from $41.00 to $19.00 in a report released on Wednesday, Analyst Ratings Network reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s target price would suggest a potential upside of 11.11% from the company’s […]

Related Keywords

United States ,Andrew Slutsky ,Raymond James ,Analyst Ratings Network ,Morgan Stanley ,Deutsche Bank Aktiengesellschaft ,Creative Financial Designs Inc ,First Horizon Advisors Inc ,Goodrx Company Profile Get Rating ,Goodrx Holdings Inc ,Advisors Inc ,Jefferies Financial Group ,Idea Men Llc ,Get Rating ,Bank Aktiengesellschaft ,Idea Men ,Horizon Advisors ,Wealth Management ,Creative Financial Designs ,Goodrx ,Nasdaq Gdrx ,Gdrx ,Medical ,Lower Price Target ,